Reference 1: 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
List of authors.
Kevin Kalinsky, M.D., William E. Barlow, Ph.D., Julie R. Gralow, M.D., Funda Meric-Bernstam, M.D., Kathy S. Albain, M.D., Daniel F. Hayes, M.D., Nancy U. Lin, M.D., Edith A. Perez, M.D., Lori J. Goldstein, M.D., Stephen K.L. Chia, M.D., Sukhbinder Dhesy-Thind, M.D., Priya Rastogi, M.D., et al. Reference 2: Does “Two is Better Than One” Apply to Surgeons? Comparing
Single-Surgeon versus Co-surgeon Bilateral Mastectomies
Melissa Anne Mallory, MD1,*
, Katya Losk, MPH2,*
, Kristen Camuso, MPH2, Stephanie
Caterson, MD3, Suniti Nimbkar, MD1,†, and Mehra Golshan, MD1,†
1Department of Surgery, Brigham and Women’s Hospital/Harvard Medical School and DanaFarber Cancer Institute, Boston, MA Reference 3: Preoperative MRI and Its Impact on Surgical Outcomes
in Patients with Triple Negative Breast Cancer Treated
with Primary Surgery: Did New Margin Guidelines or Cavity
Shave Margins Practice Diminish the Role of Preoperative MRI?
Laura Burkbauer, MD1
, Macy Goldbach, BS1 , Daniel I. Hoffman, MD1
, Andreas Giannakou, MD2
,
Rachel Dultz, MD, FACS3
, Ari D. Brooks, MD, FACS1
, Dahlia M. Sataloff, MD, FACS4
,
Luke Keele, PhD5
, and Julia Tchou, MD, PhD, FACS
